AMCP Press & News
Stay up-to-date with the latest press and news releases, covering significant updates and actions taken by AMCP. Explore comprehensive articles, statements, and announcements that highlight the organization's efforts and achievements. Stay connected with important developments and insights from the world of managed care pharmacy.
Latest Press Releases
AMCP In the News
Sanchita Galgalikar, MBA, BS, will serve as the 2023–2024 Executive Fellow in Health Care Association Leadership. This year-long training program provides a rich, in-depth learning experience for pharmacists interested in health care association leadership or managed care pharmacy.
AMCP applauds the introduction of the Access to Prescription Digital Therapeutics Act of 2023 into the Senate and House by a bipartisan group of Senators and Representatives. The bill would authorize coverage of prescription digital therapeutics by Medicare and Medicaid, helping millions of Americans receive innovative care to treat a growing range of conditions and illnesses.
AMCP applauds Congress for passing the Pre-approval Information Exchange (PIE) Act of 2022. This bipartisan bill will enhance proactive information-sharing on new treatments between drug manufacturers and health plans.
Congratulations to Zachary Brunko, PharmD candidate at the University of Minnesota College of Pharmacy, for completing AMCP Foundation’s first inaugural internship devoted to addressing health inequities.
Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP Foundation’s Best Poster Awards at Nexus 2022. This semiannual competition, proudly presented by AMCP Foundation with support from CVS Health, culminates twice a year at AMCP national meetings.
AMCP Foundation congratulates the student pharmacists who recently completed immersive managed care centered internships on oncology, health outcomes, nonprofit leadership, and evidence, through the generous support of Pfizer Inc and AbbVie Inc.
Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.
AMCP mourns the passing of managed care pharmacy icon Judith Cahill. A former CEO of AMCP, Judy led the organization for more than 15 years, growing its membership from 600 to more than 6,000 managed care professionals.
On August 12, the House of Representatives voted to approve the Senate-passed Inflation Reduction Act, containing significant health policy reforms.
On Wednesday, June 8, the House of Representatives voted to approve the Pre-approval Information Exchange Act as part of the Food & Drug Amendments of 2022 to reauthorize the FDA User Fee Agreements.
AMCP is pleased to be recognized by the Office of Disease Prevention and Health Promotion within the U.S. Department of Health and Human Services as a Healthy People 2030 Champion.
